Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Sevelda

Showing results (141-150 of 148) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 148 results.
Gynakologisch-Geburtshilfliche Rundschau|January 12, 2000
[Guidelines for treatment of breast carcinoma by the Gynecological Oncology Working Group. Gynecological Oncology Working Group]H Concin, W Grünberger, E Kubista, et al.
Anticancer Research|March 1, 1996
Influence of delayed diagnosis on established prognostic factors in endometrial cancerA Obermair, E Hanzal, I Schreiner-Frech, et al.
Gynakologisch-Geburtshilfliche Rundschau|July 11, 1998
[Guidelines for the management of simple ovarian cysts. A consensus report by AGO and AGE by request of OGGG. Austrian Society of Gynecology and Obstetrics]M Fabsits, L Fuith, G Keckstein, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 1998
Very low-dose adjuvant chemotherapy in steroid receptor negative stage I breast cancer patients. Austrian Breast Cancer Study GroupR Jakesz, H Samonigg, M Gnant, et al.
Lancet (London, England)|April 20, 1996
Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survivalR D Gelber, B F Cole, A Goldhirsch, et al.
Lancet (London, England)|February 24, 2001
Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinomaI Vergote, J De Brabanter, A Fyles, et al.
Zentralblatt Fur Chirurgie|March 4, 1999
[Therapy studies of the Austrian Breast Cancer Group (ABC)]R Jakesz, H Hausmaninger, H Samonigg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2014
Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12M Gnant, B Mlineritsch, H Stoeger, et al.
Pageof 15

Showing results (141-150 of 148) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 148 results.
Gynakologisch-Geburtshilfliche Rundschau|January 12, 2000
[Guidelines for treatment of breast carcinoma by the Gynecological Oncology Working Group. Gynecological Oncology Working Group]H Concin, W Grünberger, E Kubista, et al.
Anticancer Research|March 1, 1996
Influence of delayed diagnosis on established prognostic factors in endometrial cancerA Obermair, E Hanzal, I Schreiner-Frech, et al.
Gynakologisch-Geburtshilfliche Rundschau|July 11, 1998
[Guidelines for the management of simple ovarian cysts. A consensus report by AGO and AGE by request of OGGG. Austrian Society of Gynecology and Obstetrics]M Fabsits, L Fuith, G Keckstein, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 1998
Very low-dose adjuvant chemotherapy in steroid receptor negative stage I breast cancer patients. Austrian Breast Cancer Study GroupR Jakesz, H Samonigg, M Gnant, et al.
Lancet (London, England)|April 20, 1996
Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survivalR D Gelber, B F Cole, A Goldhirsch, et al.
Lancet (London, England)|February 24, 2001
Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinomaI Vergote, J De Brabanter, A Fyles, et al.
Zentralblatt Fur Chirurgie|March 4, 1999
[Therapy studies of the Austrian Breast Cancer Group (ABC)]R Jakesz, H Hausmaninger, H Samonigg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2014
Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12M Gnant, B Mlineritsch, H Stoeger, et al.
Pageof 15